share_log

九洲药业(603456.SH)：拟1500万元参设合伙企业 投资于非上市公司熙华检测股权

Jiuzhou Pharmaceutical (603456.SH) plans to set up a partnership of 15 million yuan to invest in shares of unlisted company Xihua Testing

Gelonghui Finance ·  03/14 16:37

Gelonhui March 14 丨 Jiuzhou Pharmaceutical (603456.SH) announced that on March 13, 2023, Hongzhou Investment, a wholly-owned subsidiary of the company, and Ningbo Jundu Private Equity Fund Management Co., Ltd. (“Kundu Management”), Ningbo Jiefeng Hongming Venture Capital Partnership (Limited Partnership) (known as “Jiefeng Investment”), Huang Xiqiang, Zhang Ning, Gan Quan and Huang Yong signed the “Ningbo Jundu Jingming Venture Capital Partnership (Limited Partnership)” to jointly invest in Ningbo Jundu Jingming Venture Capital Partnership (Limited Partnership). The total investment pledged by the partnership is RMB 55.1 million (including this investment), and Hongzhou Investment will use its own capital as a limited partner to pledge a capital of RMB 15 million, accounting for 27.22% of the total investment pledged by the partnership.

The partnership invests exclusively in the shares of the unlisted company Xihua Testing. Xihua Testing is a company that provides high-quality and efficient integrated services from proprietary drug development to approval for listing to global pharmaceutical companies.

This page is machine-translated. Futubull tries to improve but do not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.


Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.

    Write first comment